GlassScriptPhysician profile
James W Wycoff
NPI 1457733883
$4,269.39
in general payments reported to CMS, 2019-2025
12 companies · $36.01 in 2025
The $36.01 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.76 · 2023: $494 · 2024: $3,686 · 2025: $36.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,571 · Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,571.36 |
| Food and Beverage | $644.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,590.57 | 2024 | Solus Alif, Other - Miscellaneous |
| Haemonetics Corporation | $216.99 | 2023 | Teg6s Hemostasis System |
| Access Pro Medical, LLC | $173.40 | 2023 | Matriderm |
| Avita Medical Americas, LLC | $103.12 | 2023 | Recell |
| Depuy Synthes Sales INC. | $35.40 | 2021 | |
| Becton, Dickinson and Company | $32.37 | 2024 | Phasix Mesh |
| Kerecis Limited | $23.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Vericel Corporation | $23.75 | 2024 | Nexobrid |
| Alexion Pharmaceuticals, INC. | $18.36 | 2021 | |
| Polynovo North America LLC | $18.29 | 2025 | Novosorb Btm |
| Solventum Corporation | $17.72 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $15.56 | 2024 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wycoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.